OBJECTIVE: There is still a group of @entity1 that have unpredictable risk for the development of contrast @entity8 (CN). There is also an effort to find more effficient strategies to prevent CN. @entity1405 , @entity1406 and @entity23191 seem to have theoretical potentials for the prevention of CN. In this study, we aimed to investigate their effects on the prevention of CN. We also aimed to define the risk factors associated with the development of CN in our study group. METHODS: In this prospective, cross-sectional study, the @entity1 were divided into four groups according to whether they were taking 25 mg/day @entity1405 (n:56), 5 mg/day @entity23191 (n:60), 50 mg/day @entity1406 (n:68) or none (n:63). We made analysis to determine the agents' efficiency on the prevention of CN. We also performed multiple logistic regression analysis including all groups to define the risk factors associated with CN. RESULTS: The incidents of CN were the lowest in the @entity1405 group (4%) while the worst performance occurred in those taking @entity1406 (10%). The difference between the groups in terms of the development of CN did not reach statistical significance (p>0.05). Multiple logistic regression analysis showed age (p=0.003), higher @entity412 levels (p=0.011) and family history of @entity453 (p=0.038) to be the predictors of CN. CONCLUSION: In this study, we didn't find any relation between the development of CN and @entity1405 , @entity1406 or @entity23191 usage. We found age, higher levels of @entity412 and family history of @entity453 to be risk factors for predicting CN.

A clinical study about contrast XXXX : risk factors and the role of beta blockers.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity23191 :: ('MESH:C052753', 'Chemical') :: ['nebivolol'] @entity8 :: ('MESH:D007674', 'Disease') :: ['nephropathy'] @entity1405 :: ('MESH:C043211', 'Chemical') :: ['carvedilol', 'Carvedilol'] @entity1406 :: ('MESH:D008790', 'Chemical') :: ['metoprolol'] @entity412 :: ('CHEBI:17855', 'Chemical') :: ['triglyceride'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease']
@entity8 :: (MESH:D007674,Disease) :: ['nephropathy']
